ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Graft survival"

  • 2017 American Transplant Congress

    Retrospective Analysis of Kidney Transplant Recipients with Antibody-Mediated Rejection.

    G. Piñeiro,1 E. Desousa,1 J. Villarreal,1 M. Lozano,2 J. Cid,2 M. Sole,3 F. Oppenheimer,1 F. Diekmann.1

    1Nephrology and Renal Transplant, Hospital Clinic de Barcelona, Barcelona, Spain; 2Apheresis Unit, Department of Hemotherapy and Hemostasis, Hospital Clinic de Barcelona, Barcelona, Spain; 3Pathology, Hospital Clinic de Barcelona, Barcelona, Spain

    Acute antibody mediated rejection (AMR) is a major cause of allograft loss.We retrospectively reviewed all kidney allograft recipients between 2002 and March 2016. Investigated the…
  • 2017 American Transplant Congress

    Long-Term Pediatric Live-Donor Liver Transplantation Survivors: Patient and Allograft Outcomes.

    N. Celik,1 A. Ganoza,1 G. Bond,1 K. Soltys,1 R. Sindhi,1 P. McKiernan,3 A. Humar,2 G. Mazariegos.1

    1Hillman Center for Pediatric Transplantation, Children's Hospital of Pittsburgh of UPMC, Pittsburgh, PA; 2Thomas E. Starzl Transplantation Institute, Pittsburgh, PA; 3Division of Pediatric Gastroenterology, Pittsburgh, PA

    Aim: To determine the patient and allograft outcomes at 5 years after pediatric live-donor liver transplantation (LDLT).Methods: Children with a minimum of 5-year survival post-transplantation…
  • 2017 American Transplant Congress

    A Comparative Study of Patient and Graft Qualities Between Abo-Compatible and -Incompatible Recipients More Than Ten Years After Kidney Transplantation.

    H. Ishida, T. Shimizu, M. Okumi, K. Unagami, K. Omoto, K. Tanabe.

    Urology, Tokyo Women's Medical University, Tokyo, Japan

    Background. The long-term benefits of ABO-I kidney transplantation in terms of adverse events due to severe immunosuppression immediately before transplantation remain unclear.Patients and Methods. Between…
  • 2017 American Transplant Congress

    Steroid Free Maintenance Immunosupression in Kidney Transplantation: Indiana University Experience.

    S. Hussain, T. Taber, A. Sharfuddin, M. Yaqub, W. Goggins, D. Mishler, O. Adebiyi.

    Renal Transplant, Indiana University School of Medicine, Indianapolis, IN

    Background: Steroid based maintenance Immunosuppression (IS) regimen is the standard protocol for many kidney transplant(tx) centers. However, concerns for chronic steroid impact on patients remains…
  • 2017 American Transplant Congress

    Trends in Long-Term Outcomes of Kidney Transplantation in Australia and New Zealand.

    W. Lim,1 W.-C. Yeung,2 S. Campbell,3 S. Chadban,4 P. Clayton,5 C. Hawley,3 D. Johnson,3 S. McDonald,5 E. Pascoe,6 G. Wong,7 S. Badve.2

    1Sir Charles Gairdner Hospital, Perth, Australia; 2St George Hospital, Sydney, Australia; 3Princess Alexandra Hospital, Brisbane, Australia; 4Royal Prince Alfred Hospital, Sydney, Australia; 5University of Adelaide, Adelaide, Australia; 6University of Queensland, Brisbane, Australia; 7Westmead Hospital, Sydney, Australia

    Introduction: Surgical and medical advances have led to considerable improvement in short-term outcomes of kidney transplantation, with 1-year graft and patient survival approaching 100%. However,…
  • 2016 American Transplant Congress

    Reversibility of Acute Kidney Rejection According to the Banff 2013 Classification: A Retrospective Cohort Study.

    A. Poulin,1 M. Dorais,2 L. Sénécal,3 S. Colette,3 H. Cardinal.1

    1CRCHUM, Montreal, QC, Canada; 2Statsciences, Montreal, QC, Canada; 3HMR, Montreal, QC, Canada.

    Background: Vascular involvement of the allograft has classically been regarded as a poor prognostic factor in acute kidney graft rejection. Cell-mediated endarteritis often coexists with…
  • 2016 American Transplant Congress

    Subnormothermic Machine Perfusion (SNMP) with a Novel Hemoglobin-Based Oxygen Carrier (HBOC) Solution for Ex Vivo Preservation in Vascularized Composite Allotransplantation (VCA).

    S. Oksuz, R. Schweizer, M. Minervini, B. Banan, V. Gorantla, P. Fontes.

    University of Pittsburgh, Pittsburgh.

    Background: Improved preservation techniques could reduce ischemia-reperfusion injuries (IRI) and allow better matching and allocation of VCA grafts across wider distances. A novel SNMP system…
  • 2016 American Transplant Congress

    Fluctuation of Renal Function During the First Year Is Associated with Negative Impact on Long-Term Kidney Graft Survival: A Retrospective, Propensity Score-Matched Study.

    H. Choi,1 D. Joo,2,3 M. Song,4 M. Kim,2,3 Y. Kim,2,3 B. Kim.1,3

    1Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea; 2Department of Surgery, Yonsei University College of Medicine, Seoul, Korea; 3The Research Institute for Transplantation, Yonsei University College of Medicine, Seoul, Korea; 4Department of Biostatistics Collaboration Unit, Yonsei University College of Medicine, Seoul, Korea.

    Background: Post-transplant renal function in the first year has been reported to predict long-term renal graft survival. The present study examined whether the fluctuation of…
  • 2016 American Transplant Congress

    The Impact of a Novel Dual Adenosine Triphosphate-Competitive mTOR Inhibitor (TORKinib) on Alloimmunity and Transplant Survival.

    D. Fantus,1 Y. Ono,1 S. Yokota,1 C. Komatsu,1 H. Turnquist,1,2 A. Thomson.1,2

    1Surgery, Thomas E Starzl Transplantation Institute, University of Pittsburgh School of Medicine, Pittsburgh, PA; 2Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA.

    Background: Rapamycin (RAPA), an immunosuppressive agent, inhibits the mechanistic target of Rapamycin (mTOR), the kinase subunit of two mTOR- containing complexes (mTORC1 and mTORC2). While…
  • 2016 American Transplant Congress

    Outcomes of Deceased Donor Kidney Transplantation from Diabetic Donors: Does Presence of Recipient Diabetes Matter?

    J. Rogers,1 A. Farney,1 G. Orlando,1 A. Reeves-Daniel,2 A. Palanisamy,2 H. El-Hennawy,1 M. Khan,1 M. Gautreaux,1 S. Iskandar,3 W. Doares,4 S. Kaczmorski,4 R. Stratta.1

    1Surgery, Wake Forest Baptist Medical Center, Winston-Salem, NC; 2Internal Medicine, WFBMC, Winston-Salem, NC; 3Pathology, WFBMC, Winston-Salem, NC; 4Pharmacy, WFBMC, Winston-Salem, NC.

    Donor history of diabetes mellitus (DM) is a known risk factor for inferior graft survival after deceased donor kidney transplantation (DDKT) and is heavily weighted…
  • « Previous Page
  • 1
  • …
  • 83
  • 84
  • 85
  • 86
  • 87
  • …
  • 113
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2026 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences